Accurate detection of recent LTBI/preclinical TB status and progression from LTBI to active TB disease can be achieved by assessing both humoral and cellular immune responses with combinations of characteristic antigens, including growth‐related ESAT6, CFP10, Ag85A, dormancy‐related MDP1, and Acr. The gene discussed is ACR; the disease is tuberculosis.